|
|
Analysis of clinical characteristics of hospitalized thrombocytopenia patients in our hospital |
YE Fang WANG Ling SUN Jianli WANG Huan LI Ningning SHU Ya′nan ZHANG Li′nan TONG Chun |
Department of Hematology, Beijing Chuiyangliu Hospital Affiliated to Tsinghua University, Beijing 100022, China |
|
|
Abstract Objective To investigate the department distribution and the causes of hospitalized patients with thrombocytopenia in Beijing Chuiyangliu Hospital Affiliated to Tsinghua University ("our hospital" for short). Methods 358 hospitalized patients with thrombocytopenia were retrospectively analysed in our hospital from August 2015 to July 2016 through the hospital information management system (HIS), the degree of thrombocytopenia, department distribution and pathogeny were monitored. Results The patients of platelet count ≤20×109/L accounted for 5.86%, the patients of platelet count >20×109~50×109/L accounted for 16.76%, the patients of platelet count >50×109~100×109/L accounted for 77.38%. The 358 patients were mainly distributed in Department of Respiratory Medicine, Department of General Surgery, Department of ICU, Department of Obstetrics and Gynecology, Department of Neurology, Department of Cardiology, Department of Haematology and other departments. 43 patients of thrombocytopenia were diagnosed with hematological system disorders, and 315 patients were diagnosed with thrombocytopenia because of other reasons, such as infection and drugs. Conclusion The main cause of thrombocytopenia patients from our hospital between 2015 and 2016 are the non-hematological system disorders. We need to attach importance to the effects of infection and drugs on thrombocyte. However those patients suffer to a lesser degree, and can be recovered by positive control of the primary reasons.
|
|
|
|
|
[1] 张之南,沈悌.血液病诊断及疗效标准[M].3版.北京:科学技术出版社,2007:1-2.
[2] 陈精予.血小板减少59例分析[J].中国误诊学杂志,2007, 7(21):5115-5116.
[3] 汪鹏程,蔡力生,刘焕勋,等.血小板减少性脑出血32例临床观察[J].临床医学实践,2006,15(4):256-258.
[4] 黄玉,李薇,杨波,等.成人难治及复发ITP的个体化治疗及研究进展[J].中国实验血液学杂志,2009,17(6):1609-1615.
[5] 王志强.免疫性血小板减少症患者外周血淋巴细胞亚群变化的研究[J].中国当代医药,2015,22(24):120-122.
[6] 杨文博.病毒感染与特发性血小板减少性紫癜[J].医学综述,2011,7(6):373.
[7] Gasbarrini A,Franceschi F,Tartaglione R,et al. Regression of autoimmune thrembocytopenia after eradication of H.pylofi [J]. Lancet,1998,352(9131):878.
[8] 武四云,李艳明,筒子娟,等.ITP患者抗幽门螺杆菌治疗的疗效观察[J].中南大学学报:医学版,2009,34(12):1251-1254.
[9] Fogarty PF,Segal JB. The epidemiology of immune thrombocytope-nic purpura [J]. Curr Opin Hematol,2007,14(5):515-519.
[10] Tephan J,Shalansky,Arun K,et al. Risk markers for thromhocytopenia in critically ill patients:a prospective analysis [J]. Pharmcothcrapy,2002,22(7):803-813.
[11] 段华新,彭浪,杨扬,等.感染所致104例血小板减少的临床研究[J].湖南师范大学学报:医学版,2014,11(2):23-26.
[12] Lindern JSV,Bruele TVD,Lopriore E,et al. Thrombocytopenia in neonates and the risk of intraventricular hemorrhage:a retrospective cohort study [J]. BMC Pediatrics,2011,11(1):1-7.
[13] George JN,Aster RH. 药物诱导的血小板减少:发病机制、评价和处理[C].//第51届美国血液年会论文集.北京:北京医学会,2013:33-38.
[14] 王京华,王春颖,谢蕊,等.肝素诱导的血小板减少症的临床研究[J].中华血液学杂志,2011,32(2):115-117.
[15] Warkentin TE. New approaches to the diagnosis of heparin-induced thrombocytopenia [J]. Chest,2005,127(2):35S-45S.
[16] Adikoylu G,Yukaelen V,Yavasoglu I,et al. Hemostatic dfects of atorvastatin versus siravastatirl [J]. Ann Pharma?鄄omher,2003,37(4):478.
[17] Von Drygalski A,Curtis BR,Bougie DW,et al. Vancomycin-induced immune thrombocytopenia [J]. N Engl J Med,2007,356(24):904-910.
[18] Macwilliam JL,Mistry R,Floyd MS,et al. Piperacillin/tazobactam induced thrombocytopaenia—a delayed response [J]. BMJ Case Rep,2012. Doi:10.1136/bcr.03.2012. 5981.
[19] 黄江平,代鸣.妊娠合并血小板减少60例临床探讨[J].中国当代医药,2016,23(17):57-59.
[20] 黄江平,代鸣.妊娠合并血小板减少症的病因学分析及其对母婴妊娠结局的影响[J].中国当代医药,2016,23(24):80-83.
[21] 陈哲,梁梅英,王建六,等.妊娠期首发血小板减少的病因学诊断及临床特点[J].中华妇产科杂志,2011,46(11):834-839.
[22] Keeling DM,Isenberg DA. Haematological manifestations of systemic lupus erythematosus [J]. Blood Rev,1993,7(4):199-207.
[23] Jung JH,Soh MS,Ahn YH,et al. Thrombocytopenia in systemic lupus erythematosus:clinical manifestations,trea?鄄tmentand prognosis in 230 patients [J]. Medicine,2016,95(6):e2818.
[24] Veenhoven WA,Vail der Schans GS,Huiges W,et al. Pseudothrombocytopenia due to agglufinina [J]. Am J Clin Path,1979,72:1005-1008. |
|
|
|